Arcadia Biosciences Inc (RKDA)
Official siteCONSUMER DEFENSIVE • PACKAGED FOODS • NASDAQ
Market Cap: $1.32M
Last updated: Nov 17, 2026 at 11:04 AM ET
Arcadia Biosciences Inc (RKDA) Valuation Multiples
Arcadia Biosciences (RKDA) trades at 0.2x sales and 0.5x book value. Its P/S of 0.2x is below its 5-year median of 0.9x. Its forward P/E is 36.6x.
Current Multiples
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 36.6x |
| Price to sales | 0.2x |
| Price to book | 0.5x |
| PEG | N/A |
Historical Medians
Against its 10-year medians, its P/S is 91.7% below 2.4x and its P/B is 54.5% below 1.1x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 0.2x | 0.9x | 2.4x |
| P/B | 0.5x | 0.5x | 1.1x |
Valuation History
Over the 9 of the 10 year ends shown that have a P/S, its P/S ranged from 0.6x in 2025 to 13.5x in 2018. 2025 was the lowest of those years.
| Year end | Price | P/S | P/B |
|---|---|---|---|
| 2025 | $1.98 | 0.6x | 0.7x |
| 2024 | $5.92 | 1.6x | 1.3x |
| 2023 | $3.13 | 0.8x | 0.3x |
| 2022 | $10.84 | 0.8x | 0.3x |
| 2021 | $41.60 | 3.3x | 0.7x |
| 2020 | $101.20 | 4.0x | 1.2x |
| 2019 | $219.20 | N/A | N/A |
| 2018 | $126.80 | 13.5x | 47.3x |
| 2017 | $220.00 | 2.9x | 1.5x |
| 2016 | $736.00 | 12.8x | 1.8x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About RKDA
What is RKDA's forward P/E ratio?
Arcadia Biosciences has a forward P/E ratio of 36.6x.
Is RKDA stock overvalued?
GNG's valuation label for RKDA is Undervalued.
What is RKDA's price to sales ratio?
Arcadia Biosciences has a price to sales ratio of 0.2x.
RKDA pages: Overview, Earnings, Financials, Valuation, Competitors